| Name | Title | Contact Details |
|---|
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
BewellConnect Corp. is an ecosystem of connected devices and services that enhance care coordination.
Hycor Biomedical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
New Mexico Cancer Center is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.